Clinical trial
Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
NCT00418704 · Groupe Francais De Pneumo-Cancerologie, Other · Completed
Key facts
| NCT number | NCT00418704 |
|---|---|
| Title | Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) |
| Official title | A Multicenter Randomized Phase II Trial in NSCLC Stage IV and IIIB (T4 With Pleural Effusion) in Elderly Independent Patients the Schedule Docetaxel / Gemcitabine First Line Following by Erlotinib When Progression Versus Erlotinib First Line Following by/ Gemcitabine When Progression. |
| Lead sponsor | Groupe Francais De Pneumo-Cancerologie, Other |
| Collaborators | Sanofi Industry Chugai Pharma USA |
| Status | Completed |
| Study type | Observational |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Erlotinib, taxotere |
| Enrollment | 100 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2009 |
| First posted | Jan 5, 2007 |
| Last update posted | Oct 1, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: